US FDA creates new task force and “blog” to increase transparency
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration, in order to increase transparency around its decision-making process, has established a task force that will look at ways to provide the public with useful and understandable information about the agency’s activities in a more timely and user-friendly format1.